{"id":"https://openalex.org/W2165916281","doi":"https://doi.org/10.1111/j.1365-2141.2007.06916.x","title":"Estimation of dose requirements for sustainedin vivoactivity of a therapeutic human anti\u2010CD20 antibody","display_name":"Estimation of dose requirements for sustainedin vivoactivity of a therapeutic human anti\u2010CD20 antibody","publication_year":2007,"publication_date":"2007-11-28","ids":{"openalex":"https://openalex.org/W2165916281","doi":"https://doi.org/10.1111/j.1365-2141.2007.06916.x","mag":"2165916281","pmid":"https://pubmed.ncbi.nlm.nih.gov/18045353"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2141.2007.06916.x","doi":"https://doi.org/10.1111/j.1365-2141.2007.06916.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2141.2007.06916.x","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://dspace.library.uu.nl/handle/1874/32094","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109196174","display_name":"Wim K. Bleeker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102253","display_name":"Genmab (Netherlands)","ror":"https://ror.org/01ajp8153","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210102253","https://openalex.org/I4210163256"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Wim K. Bleeker","raw_affiliation_strings":["Genmab, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genmab, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I4210102253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108210888","display_name":"Martin E. Munk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163256","display_name":"Genmab (Denmark)","ror":"https://ror.org/057pe1087","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210163256"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Martin E. Munk","raw_affiliation_strings":["Genmab, Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genmab, Copenhagen, Denmark","institution_ids":["https://openalex.org/I4210163256"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005297214","display_name":"Wendy J.M. Mackus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102253","display_name":"Genmab (Netherlands)","ror":"https://ror.org/01ajp8153","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210102253","https://openalex.org/I4210163256"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Wendy J. M. Mackus","raw_affiliation_strings":["Genmab, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genmab, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I4210102253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009363849","display_name":"Jeroen H. N. van den Brakel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102253","display_name":"Genmab (Netherlands)","ror":"https://ror.org/01ajp8153","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210102253","https://openalex.org/I4210163256"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Jeroen H. N. Van Den Brakel","raw_affiliation_strings":["Genmab, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genmab, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I4210102253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055810116","display_name":"Marielle Pluyter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102253","display_name":"Genmab (Netherlands)","ror":"https://ror.org/01ajp8153","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210102253","https://openalex.org/I4210163256"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Marielle Pluyter","raw_affiliation_strings":["Genmab, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genmab, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I4210102253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074087478","display_name":"Martin J. Glennie","orcid":"https://orcid.org/0000-0001-8962-5901","observed_orcids":["https://orcid.org/0000-0001-8962-5901"]},"institutions":[{"id":"https://openalex.org/I2802965805","display_name":"University Hospital Southampton NHS Foundation Trust","ror":"https://ror.org/0485axj58","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802965805"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Martin J. Glennie","raw_affiliation_strings":["Tenovus Research Laboratory, Cancer Sciences Division, School of Medicine, University General Hospital, Southampton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tenovus Research Laboratory, Cancer Sciences Division, School of Medicine, University General Hospital, Southampton, UK","institution_ids":["https://openalex.org/I2802965805"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111865986","display_name":"Jan G. J. van de Winkel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]},{"id":"https://openalex.org/I4210102253","display_name":"Genmab (Netherlands)","ror":"https://ror.org/01ajp8153","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210102253","https://openalex.org/I4210163256"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Jan G. J. Van De Winkel","raw_affiliation_strings":["Genmab, Utrecht, The Netherlands","Immunotherapy Laboratory, Department of Immunology, University Medical Centre, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genmab, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I4210102253"]},{"raw_affiliation_string":"Immunotherapy Laboratory, Department of Immunology, University Medical Centre, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I3018483916"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039190287","display_name":"Paul W.H.I. Parren","orcid":"https://orcid.org/0000-0002-4365-3859","observed_orcids":["https://orcid.org/0000-0002-4365-3859"]},"institutions":[{"id":"https://openalex.org/I4210102253","display_name":"Genmab (Netherlands)","ror":"https://ror.org/01ajp8153","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210102253","https://openalex.org/I4210163256"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Paul W. H. I. Parren","raw_affiliation_strings":["Genmab, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genmab, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I4210102253"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5039190287"],"corresponding_institution_ids":["https://openalex.org/I4210102253"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":null,"fwci":5.4468,"has_fulltext":false,"cited_by_count":90,"citation_normalized_percentile":{"value":0.95929888,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"140","issue":"3","first_page":"303","last_page":"312"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9711999893188477,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9711999893188477,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.013399999588727951,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.005400000140070915,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ofatumumab","display_name":"ofatumumab","score":1.0},{"id":"https://openalex.org/keywords/anti-cd20-monoclonal-antibody","display_name":"anti-CD20 monoclonal antibody","score":0.9739999771118164},{"id":"https://openalex.org/keywords/dose-requirement","display_name":"dose requirement","score":0.6510000228881836},{"id":"https://openalex.org/keywords/b-cell-depletion","display_name":"B-cell depletion","score":0.7760000228881836},{"id":"https://openalex.org/keywords/antibody-pharmacokinetics","display_name":"antibody pharmacokinetics","score":0.8190000057220459},{"id":"https://openalex.org/keywords/tumor-burden","display_name":"tumor burden","score":0.859000027179718},{"id":"https://openalex.org/keywords/maintenance-immunotherapy","display_name":"maintenance immunotherapy","score":0.9470000267028809},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.6959999799728394}],"concepts":[{"id":"https://openalex.org/C2778714382","wikidata":"https://www.wikidata.org/wiki/Q410656","display_name":"Ofatumumab","level":4,"score":0.8456407785415649},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.6659549474716187},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6277486085891724},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6033458709716797},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5993582606315613},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.525169312953949},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5224907994270325},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5102007389068604},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5008790493011475},{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.4795134365558624},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4553956389427185},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.44016680121421814},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3135431408882141},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.30569469928741455},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000920","descriptor_name":"Antibody-Dependent Cell Cytotoxicity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001402","descriptor_name":"B-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D008252","descriptor_name":"Macaca fascicularis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D016513","descriptor_name":"Mice, SCID","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018951","descriptor_name":"Antigens, CD20","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":8,"locations":[{"id":"doi:10.1111/j.1365-2141.2007.06916.x","doi":"https://doi.org/10.1111/j.1365-2141.2007.06916.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2141.2007.06916.x","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:18045353","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18045353","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Journal Article"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/2c861b42-e215-4464-85c3-95954139ecde","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/2c861b42-e215-4464-85c3-95954139ecde","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bleeker, W K, Munk, M E, Mackus, W J M, van den Brakel, J H N, Pluyter, M, Glennie, M J, van de Winkel, J G J & Parren, P W H I 2008, 'Estimation of dose requirements for sustained in vivo activity of a therapeutic human anti-CD20 antibody', British Journal of Haematology, vol. 140, no. 3, pp. 303-312. https://doi.org/10.1111/j.1365-2141.2007.06916.x","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:dspace.library.uu.nl:1874/32094","doi":null,"is_oa":true,"landing_page_url":"https://dspace.library.uu.nl/handle/1874/32094","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:oai:eprints.soton.ac.uk:153871","doi":null,"is_oa":false,"landing_page_url":"https://eprints.soton.ac.uk/153871/","pdf_url":null,"source":{"id":"https://openalex.org/S4306401019","display_name":"ePrints Soton (University of Southampton)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I43439940","host_organization_name":"University of Southampton","host_organization_lineage":["https://openalex.org/I43439940"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/2c861b42-e215-4464-85c3-95954139ecde","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/2c861b42-e215-4464-85c3-95954139ecde","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"British Journal of Haematology, 140(3), 303 - 312. Wiley","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:umcu:oai:dspace.library.uu.nl:1874/32094","doi":null,"is_oa":true,"landing_page_url":"https://dspace.library.uu.nl/handle/1874/32094","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"British Journal of Haematology, 140(3), 303. Wiley-Blackwell","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:uu:oai:dspace.library.uu.nl:1874/32094","doi":null,"is_oa":true,"landing_page_url":"http://dspace.library.uu.nl/handle/1874/32094","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"British Journal of Haematology, 140(3), 303","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:dspace.library.uu.nl:1874/32094","doi":null,"is_oa":true,"landing_page_url":"https://dspace.library.uu.nl/handle/1874/32094","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1533841403","https://openalex.org/W1675831178","https://openalex.org/W1900061753","https://openalex.org/W1959625971","https://openalex.org/W1992545809","https://openalex.org/W1998665610","https://openalex.org/W2009673033","https://openalex.org/W2016112355","https://openalex.org/W2036369606","https://openalex.org/W2041088430","https://openalex.org/W2050754173","https://openalex.org/W2063792914","https://openalex.org/W2079365532","https://openalex.org/W2094005920","https://openalex.org/W2112476236","https://openalex.org/W2116547757","https://openalex.org/W2122725450","https://openalex.org/W2128402413","https://openalex.org/W2139256276","https://openalex.org/W2141139539","https://openalex.org/W2142492861","https://openalex.org/W2144307849","https://openalex.org/W2155284019","https://openalex.org/W2156522119","https://openalex.org/W2168648203","https://openalex.org/W2168750246","https://openalex.org/W2588417621","https://openalex.org/W4313379100","https://openalex.org/W6632130792"],"related_works":["https://openalex.org/W2147639736","https://openalex.org/W2109775395","https://openalex.org/W7099487764","https://openalex.org/W2949596811","https://openalex.org/W4367304755","https://openalex.org/W78060682","https://openalex.org/W7047712219","https://openalex.org/W2788060060","https://openalex.org/W1594284322","https://openalex.org/W2806121327"],"abstract_inverted_index":{"We":[0,112],"evaluated":[1],"the":[2,19,120],"dose":[3],"requirements":[4],"for":[5,18,143,153,157],"sustained":[6,144],"in":[7,34,48,72],"vivo":[8],"activity":[9],"of":[10,21,40,86,98,117,163],"ofatumumab,":[11],"a":[12,26,30,151],"human":[13,54],"anti-CD20":[14],"antibody":[15,38,80],"under":[16],"development":[17],"treatment":[20],"B":[22,91],"cell-mediated":[23],"diseases.":[24],"In":[25,82],"mouse":[27],"xenograft":[28],"model,":[29],"single":[31],"dose,":[32],"resulting":[33],"an":[35],"initial":[36,84,127,161],"plasma":[37,62,129],"concentration":[39],"5":[41],"microg/ml,":[42],"which":[43],"was":[44],"expected":[45,69],"to":[46,70],"result":[47,71],"full":[49],"target":[50,133],"saturation,":[51],"effectively":[52],"inhibited":[53],"B-cell":[55,99],"tumour":[56,76],"development.":[57],"Tumour":[58],"growth":[59],"resumed":[60],"when":[61,105],"concentrations":[63,130],"dropped":[64,108],"below":[65,109],"levels":[66,107],"that":[67,131],"are":[68,140],"half-maximal":[73],"saturation.":[74],"Notably,":[75],"load":[77],"significantly":[78],"impacted":[79],"pharmacokinetics.":[81],"monkeys,":[83],"depletion":[85,162],"circulating":[87,136],"and":[88],"tissue":[89],"residing":[90],"cells":[92,137],"required":[93],"relatively":[94],"high-dose":[95],"levels.":[96],"Re-population":[97],"compartments,":[100],"however,":[101],"only":[102],"became":[103],"detectable":[104],"ofatumumab":[106],"10":[110],"microg/ml.":[111],"conclude":[113],"that,":[114],"once":[115],"saturation":[116,134],"CD20":[118,164],"throughout":[119],"body":[121],"has":[122],"been":[123],"reached":[124],"by":[125],"high":[126],"dosing,":[128],"maintain":[132],"on":[135],"(5-10":[138],"microg/ml)":[139],"probably":[141],"sufficient":[142],"biological":[145],"activity.":[146],"These":[147],"observations":[148],"may":[149],"provide":[150],"rationale":[152],"establishing":[154],"dosing":[155],"schedules":[156],"maintenance":[158],"immunotherapy":[159],"following":[160],"positive":[165],"(tumour)":[166],"cells.":[167]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":12},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}